[15] [39] [40] In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
Injectable IGF-1 analogues are not FDA-approved for muscle building, IGF-1 misuse in sport is a documented problem (Guha et al., Current Drug Abuse Reviews , 2009), and there is essentially no human trial evidence supporting IGF-1 LR3 for muscle growth
CJC-1295 Ipamorelin is a growth hormone peptide stack that stimulates your own pituitary to release your own growth hormone
As always, any medication decisions should be made with the supervision and collaboration of your physician
When they fail to do so, they can be held accountable
429 Rivastigmine was first approved by the FDA for the treatment of mild-to-moderate AD in 2000